9999999997-17-006501.txt : 20170524 9999999997-17-006501.hdr.sgml : 20170524 20170524144510 ACCESSION NUMBER: 9999999997-17-006501 CONFORMED SUBMISSION TYPE: CT ORDER PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20170524 DATE AS OF CHANGE: 20170524 20170524 20170524 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Revance Therapeutics, Inc. CENTRAL INDEX KEY: 0001479290 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 770551645 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: CT ORDER SEC ACT: 1934 Act SEC FILE NUMBER: 001-36297 FILM NUMBER: 17866406 BUSINESS ADDRESS: STREET 1: 7555 GATEWAY BLVD. CITY: NEWARK STATE: CA ZIP: 94560 BUSINESS PHONE: 510-742-3400 MAIL ADDRESS: STREET 1: 7555 GATEWAY BLVD. CITY: NEWARK STATE: CA ZIP: 94560 CT ORDER 1 filename1.pdf begin 644 filename1.pdf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